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BACKGROUND
•  Loperamide is a non-prescription anti-diarrhea medication
•  Mechanism of action involves opioid agonism to inhibit intestinal 
peristalsis, calcium channel blockade, and a decrease in 
paracellular permeability
•  At therapeutic doses, loperamide has low oral bioavailability and 
minimal central nervous system (CNS) penetration
•  At supratherapeutic doses, loperamide can penetrate the CNS 
and is being increasingly used recreationally to alleviate the 
symptoms of opioid withdrawal as well as induce euphoria. 
DISCUSSION
•  Loperamide’s half-life at therapeutic doses is 9-13 hours with 30-40% fecal 
excretion
•  Due to Loperamide’s mu-receptor agonism, gastrointestinal motility is reduced 
and therefore loperamide overdose likely leads to prolonged toxicity from delayed 
absorption and reduced elimination of the drug
•  It is important for physicians to recognize the abuse potential of loperamide and 
to understand the treatment of its toxic effects during an era of growing opioid 
epidemic
•  The relatively low cost of loperamide coupled with its opioid-like effects at 
high doses has made it an emerging drug of abuse with potentially lethal 
consequences
A 39 year-old woman with past medical history of intravenous drug 
and alcohol abuse and hepatitis C presented to the emergency room 
due to seizure-like activity. Family reported loss of consciousness with 
associated tonic-clonic movements of her upper extremities. The patient 
had eight similar episodes of seizure-like activity while at work prior to 
presenting to the emergency department where she had an additional 
witnessed event. Telemetry monitoring during the episode revealed 
torsades de pointes. Her admission electrocardiogram (EKG) revealed a 
QTc of 687 ms. Urine drug screen was negative, however she admitted 
to abusing loperamide. Initially taking 20 pills per day, she increased the 
dose over several months to 100 pills per day. The patient was admitted 
to the cardiac intensive care unit and placed on an isoproterenol drip 
to maintain a heart rate greater than 100 beats per minute to prevent 
R-on-T phenomenon and therefore further episodes of torsades 
de pointes. Serum magnesium and potassium levels were closely 
monitored and repleted as appropriate. The patient’s serum loperamide 
level on admission was lethally elevated at 76 ng/mL and trended down 
significantly to 30 ng/mL on day two, 9.3 ng/mL on day three, and was 
undetectable on day four. She was gradually weaned off isoproterenol 
after 5 days of therapy. Her QTc normalized and she was discharged 
home in stable condition after seven days.
CASE PRESENTATION
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